DAC
PFE icon

Dividend Assets Capital’s Pfizer PFE Stock Holding History

Dividend Assets Capital’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-7,881
Closed -$201K – 143
2025
Q3 		$201K Buy
+7,881
New +$195K 0.04% 142
2025
Q1 		– Sell
-10,884
Closed -$289K – 145
2024
Q4 		$289K Hold
10,884
– – 0.06% 126
2024
Q3 		$315K Sell
10,884
-154
-1% -$4.49K 0.06% 121
2024
Q2 		$309K Sell
11,038
-1,866
-14% -$51.4K 0.06% 118
2024
Q1 		$358K Buy
12,904
+50
+0.4% +$1.39K 0.08% 115
2023
Q4 		$370K Sell
12,854
-9,450
-42% -$286K 0.07% 122
2023
Q3 		$740K Sell
22,304
-821
-4% -$29K 0.15% 92
2023
Q2 		$848K Sell
23,125
-8,795
-28% -$342K 0.17% 96
2023
Q1 		$1.64M Hold
31,920
– – 0.35% 65
2022
Q4 		$1.64M Buy
31,920
+137
+0.4% +$6.57K 0.35% 65
2022
Q3 		$1.39M Buy
31,783
+329
+1% +$16K 0.32% 72
2022
Q2 		$1.65M Buy
31,454
+825
+3% +$42K 0.36% 70
2022
Q1 		$1.59M Sell
30,629
-230
-0.7% -$11.9K 0.3% 78
2021
Q4 		$1.82M Sell
30,859
-300
-1% -$14.9K 0.34% 72
2021
Q3 		$1.34M Sell
31,159
-300
-1% -$13.3K 0.27% 86
2021
Q2 		$1.23M Sell
31,459
-350
-1% -$13.6K 0.24% 91
2021
Q1 		$1.15M Sell
31,809
-505
-2% -$17.9K 0.22% 95
2020
Q4 		$1.19M Sell
32,314
-981
-3% -$36K 0.23% 82
2020
Q3 		$1.16M Buy
33,295
+1,036
+3% +$36.3K 0.28% 71
2020
Q2 		$1M Buy
32,259
+293
+0.9% +$9.95K 0.21% 85
2020
Q1 		$990K Buy
31,966
+3,020
+10% +$103K 0.24% 81
2019
Q4 		$1.08M Buy
28,946
+6,102
+27% +$217K 0.17% 94
2019
Q3 		$779K Sell
22,844
-85
-0.4% -$3.09K 0.13% 104
2019
Q2 		$942K Sell
22,929
-316
-1% -$12.5K 0.15% 100
2019
Q1 		$937K Hold
23,245
– – 0.15% 100
2018
Q4 		$963K Sell
23,245
-13,070
-36% -$543K 0.17% 95
2018
Q3 		$1.52M Sell
36,315
-5,681
-14% -$219K 0.19% 91
2018
Q2 		$1.45M Buy
41,996
+106
+0.3% +$3.62K 0.19% 88
2018
Q1 		$1.41M Sell
41,890
-2,287
-5% -$78.6K 0.07% 89
2017
Q4 		$1.52M Buy
44,177
+2,108
+5% +$71.9K 0.07% 86
2017
Q3 		$1.43M Sell
42,069
-2,834
-6% -$91.1K 0.06% 85
2017
Q2 		$1.43M Buy
44,903
+5,892
+15% +$186K 0.06% 83
2017
Q1 		$1.27M Buy
39,011
+4,778
+14% +$151K 0.05% 82
2016
Q4 		$1.05M Buy
34,233
+11,346
+50% +$346K 0.04% 77
2016
Q3 		$735K Buy
22,887
+3,890
+20% +$130K 0.02% 74
2016
Q2 		$635K Buy
18,997
+4,405
+30% +$141K 0.02% 81
2016
Q1 		$410K Buy
14,592
+3,494
+31% +$99.8K 0.01% 95
2015
Q4 		$340K Sell
11,098
-194
-2% -$6.1K 0.01% 109
2015
Q3 		$336K Buy
11,292
+222
+2% +$7.12K 0.01% 108
2015
Q2 		$352K Hold
11,070
– – 0.01% 113
2015
Q1 		$365K Hold
11,070
– – 0.01% 111
2014
Q4 		$327K Sell
11,070
-330
-3% -$9.46K 0.01% 120
2014
Q3 		$320K Buy
11,400
+199
+2% +$5.58K 0.01% 123
2014
Q2 		$315K Sell
11,201
-121
-1% -$3.45K 0.01% 122
2014
Q1 		$345K Sell
11,322
-1,214
-10% -$36.2K 0.01% 116
2013
Q4 		$364K Buy
12,536
+658
+6% +$19.1K 0.01% 114
2013
Q3 		$324K Sell
11,878
-219
-2% -$5.96K 0.01% 112
2013
Q2 		$321K Buy
+12,097
New +$334K 0.01% 108

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Dividend Assets Capital's PFE Position: Q4 2025 in Review

Dividend Assets Capital sold out of Pfizer (PFE) in Q4 2025, closing a stake of 7,881 shares — an estimated $201K sold.

Dividend Assets Capital first reported a position in PFE in Q2 2013 and held it in 48 quarters. The position peaked at $1.82M in Q4 2021. 2,914 funds tracked by Wall St. Rank hold PFE as of Q4 2025.

  • Dividend Assets Capital reported no remaining Pfizer position as of Q4 2025 after selling out during the quarter.
  • Dividend Assets Capital sold 7,881 Pfizer shares in Q4 2025, an estimated $201K.
  • Dividend Assets Capital first reported a position in Pfizer in Q2 2013 and held it in 48 quarters.
  • Dividend Assets Capital's Pfizer position peaked at $1.82M in Q4 2021.
  • 2,914 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.

Based on Dividend Assets Capital's 13F filing for Q4 2025, filed 12 Feb 2026.